Peptone at NVIDIA GTC 2026: Tackling the "Undruggable" Proteome
Kamil Tamiola Kamil Tamiola

Peptone at NVIDIA GTC 2026: Tackling the "Undruggable" Proteome

Intrinsically disordered proteins drive devastating diseases yet remain beyond the reach of structure-based drug discovery. At GTC 2026, Peptone's Carlo Fisicaro and Michele Invernizzi will present our flow-matching generative model that predicts conformational ensembles directly from sequence — grounded in experimental constraints and accelerated on NVIDIA's DGX platform — turning intractable disordered targets into actionable drug discovery programs.

Read More
Peptone partners with Evotec
Kamil Tamiola Kamil Tamiola

Peptone partners with Evotec

Peptone's partnership with Evotec tackles "undruggable" proteins using our HDX-MS platform & their expertise to speed up drug discovery.

Read More
Peptone at NeurIPS 2024 Conference
Kamil Tamiola Kamil Tamiola

Peptone at NeurIPS 2024 Conference

AI team introduces ProteinMPNN-ddG for estimating protein stability changes from mutations, enhancing speed and efficiency with GPU support.

Read More
Peptone profiled by Nature Biotechnology
Kamil Tamiola Kamil Tamiola

Peptone profiled by Nature Biotechnology

Peptone’s Chief Executive Officer, Dr. Kamil Tamiola, and our Chief Business Officer, Dr. Benjamin Owens, were featured in an editorial issue titled“Peptone: Finding Opportunity in Disorder” by Michael Eisenstein of Nature Biotechnology.

Read More